- Home
- BDTX vs DERM Comparison
BDTX vs DERM Comparison
Compare BDTX & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDTX
- DERM
- Stock Information
- Founded
- BDTX 2014
- DERM 2014
- Country
- BDTX United States
- DERM United States
- Employees
- BDTX N/A
- DERM N/A
- Industry
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- DERM Biotechnology: Pharmaceutical Preparations
- Sector
- BDTX Health Care
- DERM Health Care
- Exchange
- BDTX Nasdaq
- DERM Nasdaq
- Market Cap
- BDTX 181.4M
- DERM 165.6M
- IPO Year
- BDTX 2020
- DERM 2021
- Fundamental
- Price
- BDTX $2.93
- DERM $7.68
- Analyst Decision
- BDTX Strong Buy
- DERM Strong Buy
- Analyst Count
- BDTX 6
- DERM 1
- Target Price
- BDTX $14.83
- DERM $9.00
- AVG Volume (30 Days)
- BDTX 969.2K
- DERM 121.8K
- Earning Date
- BDTX 08-05-2025
- DERM 08-11-2025
- Dividend Yield
- BDTX N/A
- DERM N/A
- EPS Growth
- BDTX N/A
- DERM N/A
- EPS
- BDTX 0.09
- DERM N/A
- Revenue
- BDTX $70,000,000.00
- DERM $56,243,000.00
- Revenue This Year
- BDTX N/A
- DERM $28.99
- Revenue Next Year
- BDTX N/A
- DERM $52.61
- P/E Ratio
- BDTX $33.20
- DERM N/A
- Revenue Growth
- BDTX N/A
- DERM N/A
- 52 Week Low
- BDTX $1.20
- DERM $3.54
- 52 Week High
- BDTX $6.75
- DERM $8.25
- Technical
- Relative Strength Index (RSI)
- BDTX 56.77
- DERM 61.52
- Support Level
- BDTX $3.02
- DERM $7.05
- Resistance Level
- BDTX $3.28
- DERM $7.92
- Average True Range (ATR)
- BDTX 0.19
- DERM 0.39
- MACD
- BDTX -0.01
- DERM 0.05
- Stochastic Oscillator
- BDTX 53.33
- DERM 72.65
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.